A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease.
Amy L LightnerAna Otero-PineiroJane ReeseJustin ReamDouglas NachandAshley C AdamsAlexandra VanDenBosscheJacob A KurowskiPublished in: Inflammatory bowel diseases (2023)
Bone marrow-derived mesenchymal stem cells offer a safe, and likely effective, treatment approach for pediatric perianal fistulizing Crohn's disease.